Charles River Laboratories International (CRL) Market Capitalization (2009 - 2026)

Charles River Laboratories International has reported Market Capitalization for 18 years, with the latest figure at $10.3 billion in Q2 2026.

• On a quarterly basis, Market Capitalization rose 39.5% year-over-year to $10.3 billion in Q2 2026; TTM through Jun 2026 was $10.3 billion, a 39.5% increase from a year earlier, with the FY2025 full-year figure at $10.0 billion, up 5.28% from the prior year.
• Market Capitalization was $10.3 billion for Q2 2026 at Charles River Laboratories International, up from $7.7 billion in the prior quarter.
• The five-year high for Market Capitalization was $14.2 billion in Q1 2022, with the low at $7.3 billion in Q3 2025.
• Average Market Capitalization over 5 years is $10.2 billion, with a median of $10.2 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Market Capitalization plunged 58.75% in 2022, then jumped 39.5% in 2026.
• Over 5 years, Market Capitalization stood at $11.1 billion in 2022, then rose by 9.33% to $12.1 billion in 2023, then declined by 21.55% to $9.5 billion in 2024, then rose by 5.28% to $10.0 billion in 2025, then increased by 2.73% to $10.3 billion in 2026.
• The last three Market Capitalization figures came in at $10.3 billion (Q2 2026), $7.7 billion (Q1 2026), and $10.0 billion (Q4 2025), per Business Quant data.